BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Thomas Smith does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ACRSAclaris Therapeutics Inc | Buy | $7.00 | Nov 2024 | −46.4% | Miss |
 QTTBQ32 Bio Inc | Buy | $54.00 | May 2024 | −85.7% | Miss |
 EQEquillium Inc | Buy | $7.00 | Feb 2023 | +25.3% | Miss |
 CNTBConnect Biopharma Holdings Ltd | Buy | $7.00 | Feb 2023 | −13.4% | Miss |
| EQEquillium Inc | Buy | $12.00 | Sep 2022 | −66.8% | Miss |
 PRTCPureTech Health PLC | Buy | $70.00 | Aug 2022 | −19.7% | Miss |
| PRTCPureTech Health PLC | Buy | $66.00 | Jun 2022 | +30.4% | Miss |
| CNTBConnect Biopharma Holdings Ltd | Buy | $9.00 | May 2022 | +59.5% | Miss |
| PRTCPureTech Health PLC | Buy | $70.00 | Jan 2022 | −20.1% | Miss |
| CNTBConnect Biopharma Holdings Ltd | Buy | $22.00 | Jan 2022 | −84.1% | Miss |
| EQEquillium Inc | Buy | $14.00 | Jan 2022 | −67.7% | Miss |
| PRTCPureTech Health PLC | Buy | $76.00 | Aug 2021 | −36.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.